illudin s has been researched along with irofulven in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelner, MJ; McMorris, TC; Moon, SS | 1 |
| Estes, LA; Kelner, MJ; McMorris, TC; Taetle, R; Wang, W; Yu, J | 1 |
| Hoeijmakers, JH; Jaspers, NG; Kelner, MJ; McMorris, TC; Ng, JM; Raams, A; Takeda, S; Yamashita, YM | 1 |
| Comisso, M; Koeppel, F; Larsen, AK; Poindessous, V; Raymond, E; Waters, SJ | 1 |
| Dick, RA; Kensler, TW; Yu, X | 1 |
| Glatt, H; Meinl, W; Pietsch, KE; Sturla, SJ | 1 |
| Estes, LA; Kashinatham, A; Kelner, MJ; McMorris, TC; Staake, MD | 1 |
7 other study(ies) available for illudin s and irofulven
| Article | Year |
|---|---|
Reaction of irofulven with zinc and acid.
Topics: Acetic Acid; Antineoplastic Agents, Alkylating; Chromatography, Thin Layer; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Indenes; Indicators and Reagents; Inhibitory Concentration 50; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Sesquiterpenes; Zinc | 2003 |
(Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor properties.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Basidiomycota; Chromatography, Thin Layer; Crystallography, X-Ray; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Polycyclic Sesquiterpenes; Sesquiterpenes | 1996 |
Anti-tumour compounds illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways.
Topics: Animals; Antineoplastic Agents; Cell Line; CHO Cells; Cricetinae; DNA; DNA Damage; DNA Ligases; DNA Repair; DNA Replication; Humans; Mice; Mutation; Polycyclic Sesquiterpenes; Sesquiterpenes; Transcription, Genetic | 2002 |
Marked activity of irofulven toward human carcinoma cells: comparison with cisplatin and ecteinascidin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma; Cell Line, Tumor; Cisplatin; Culture Media; Dioxoles; Drug Resistance, Neoplasm; Epithelial Cells; Glutamate-Cysteine Ligase; Glutathione Transferase; Humans; Isoquinolines; Models, Chemical; Plant Extracts; Polycyclic Sesquiterpenes; rho GTP-Binding Proteins; Sesquiterpenes; Tetrahydroisoquinolines; Time Factors; Trabectedin; Tumor Suppressor Protein p53 | 2003 |
NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven.
Topics: Alcohol Oxidoreductases; Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Glutathione; Humans; Ketones; Kinetics; Mass Spectrometry; Models, Chemical; Polycyclic Sesquiterpenes; Sensitivity and Specificity; Sesquiterpenes; Time Factors; Transfection | 2004 |
Sulfotransferase-independent genotoxicity of illudin S and its acylfulvene derivatives in bacterial and mammalian cells.
Topics: Animals; Arylsulfotransferase; Cell Line; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Humans; Mutagenicity Tests; Mutagens; Mutation; Polycyclic Sesquiterpenes; Salmonella typhimurium; Sesquiterpenes; Sister Chromatid Exchange; Spiro Compounds; Sulfotransferases | 2014 |
Hydroxyurea derivatives of irofulven with improved antitumor efficacy.
Topics: Acetylation; Agaricales; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Humans; Hydroxyurea; Mice, Inbred BALB C; Neoplasms; Polycyclic Sesquiterpenes; Sesquiterpenes | 2016 |